SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-001455
Filing Date
2021-10-15
Accepted
2021-10-15 16:05:59
Documents
13
Period of Report
2021-10-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e621010_8k-immunic.htm   iXBRL 8-K 23701
2 e621010_ex10-1.htm EX-10.1 113249
  Complete submission text file 0001193805-21-001455.txt   336428

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imux-20211014.xsd EX-101.SCH 3013
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imux-20211014_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imux-20211014_pre.xml EX-101.PRE 22351
6 EXTRACTED XBRL INSTANCE DOCUMENT e621010_8k-immunic_htm.xml XML 3695
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 211326113
SIC: 2834 Pharmaceutical Preparations